Hyperkeratosis
4
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Gmdn 47102 Electrode Skin Abrasive Pad
Research Leaders
5 sponsors active, led by Wroclaw University of Health and Sport Sciences
Related Conditions
Often studied with 17 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Ultrasonographic Evaluation of Cosmetic Keratolytic Treatment of Foot Calluses and Corns
Instrumental Assessment of Plantar Hyperkeratosis in Healthy Subjects and Patients With Diabetes
A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
Research Network
Common Treatments
- Gmdn 47102 Electrode Skin Abrasive Pad1
- Topical Keratolytic Cosmetic Serum Cream1
- Investigational Skin Preparation Device1
- Instrumental Assessment Of Plantar Hyperkeratosis1
- Umdns 13230 Biopsy Punch Dermal Curette1
Active Sponsors
- Wroclaw University of Health and Sport Sciences1
- LMC Diabetes & Endocrinology Ltd.1
- Clinius Ltd1
- Mirka Ltd1
- University of Seville1
Top Investigators
LMC Healthcare
Vaasa Central Hospital, Vaasa, Finland
Related Conditions
- Onychomycosis1
- Diabetes Mellitus Type 11
- Actinic Lesion1
- Hyperkeratotic Lesion1
- Diabetes Mellitus Type 21